Immunovant Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | |
| 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.03 | – | |
| 0.37 | 0.33 | 0.45 | 0.52 | 0.66 | 0.64 | 0.62 | 0.59 | 0.66 | 0.54 | 0.70 | 0.69 | 2.42 | |
| 0.11 | 0.09 | 0.10 | 0.13 | 0.13 | 0.13 | 0.13 | 0.15 | 0.10 | 0.09 | 0.08 | 0.09 | 0.33 | |
| 0.47 | 0.43 | 0.56 | 0.65 | 0.79 | 0.78 | 0.75 | 0.74 | 0.76 | 0.63 | 0.78 | 0.78 | 2.75 | |
| -0.47 | -0.43 | -0.56 | -0.65 | -0.79 | -0.78 | -0.75 | -0.74 | -0.76 | -0.63 | -0.78 | -0.75 | -2.72 | |
| -0.44 | -0.36 | -0.52 | -0.60 | -0.74 | -0.76 | -0.70 | -0.70 | -0.73 | -0.60 | -0.74 | -0.75 | -2.62 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | -0.01 | – | – | |
| -0.45 | -0.36 | -0.52 | -0.60 | -0.74 | -0.76 | -0.70 | -0.71 | -0.73 | -0.61 | -0.73 | -0.75 | -2.62 | |
| -0.44 | -0.36 | -0.52 | -0.60 | -0.74 | -0.75 | -0.70 | -0.70 | -0.72 | -0.60 | -0.74 | -0.75 | -2.62 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.